X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-07 | TROX | Tronox Holdings Plc | Turgeon Jean Francois | Dir | P - Purchase | $3.21 | +31,150 | 772,572 | +4% | +$100,027 | ||||||
2025-08-08 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $1.32 | +675,000 | 248,372,576 | 0% | +$891,000 | ||||||
DM | 2025-08-07 | CLOV | Clover Health Investments, Corp. /De | Garipalli Vivek | Dir, 10% | P - Purchase | $2.23 | +446,980 | 1,856,247 | +32% | +$998,997 | |||||
2025-08-07 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO | P - Purchase | $4.15 | +10,000 | 2,335,731 | 0% | +$41,500 | ||||||
2025-08-05 | LOOP | Loop Industries, Inc. | Hart Spencer | Dir | P - Purchase | $1.66 | +20,000 | 360,370 | +6% | +$33,100 | ||||||
AM | 2025-08-06 | MKZR | Mackenzie Realty Capital, Inc. | Dixon Robert E | CEO, Pres | P - Purchase | $4.40 | +30,508 | 59,228 | +106% | +$134,113 | |||||
M | 2025-08-06 | MKZR | Mackenzie Realty Capital, Inc. | Simpson Christine Elizabeth | Chief Portfolio Manager | P - Purchase | $4.40 | +30,508 | 36,327 | +524% | +$134,113 | |||||
M | 2025-08-06 | MKZR | Mackenzie Realty Capital, Inc. | Sherpa Angche | CFO | P - Purchase | $4.40 | +30,508 | 36,237 | +532% | +$134,113 | |||||
M | 2025-08-06 | MKZR | Mackenzie Realty Capital, Inc. | Patterson Charles E. II | GC, Secretary | P - Purchase | $4.40 | +30,508 | 36,077 | +548% | +$134,113 | |||||
M | 2025-08-06 | MKZR | Mackenzie Realty Capital, Inc. | Fuller Glen W | TREASURER | P - Purchase | $4.40 | +30,508 | 36,077 | +548% | +$134,113 | |||||
M | 2025-08-06 | MKZR | Mackenzie Realty Capital, Inc. | Bluth Jeri Ruth | Chief Compliance Officer | P - Purchase | $4.40 | +30,508 | 36,077 | +548% | +$134,113 | |||||
2025-08-05 | LUMN | Lumen Technologies, Inc. | Johnson Kathleen E | Pres, CEO | P - Purchase | $3.69 | +135,870 | 11,895,309 | +1% | +$501,781 | ||||||
2025-08-05 | CLAR | Clarus Corp | Sokolow Nicolas | Dir | P - Purchase | $3.25 | +20,000 | 774,485 | +3% | +$64,986 | ||||||
M | 2025-08-05 | CLAR | Clarus Corp | Kanders Warren B | Exec COB, 10% | P - Purchase | $3.24 | +289,000 | 10,573,549 | +3% | +$935,690 | |||||
2025-08-07 | TROX | Tronox Holdings Plc | Jones Stephen J | Dir | P - Purchase | $3.19 | +8,000 | 146,414 | +6% | +$25,480 | ||||||
2025-08-06 | MKZR | Mackenzie Realty Capital, Inc. | Dixon Robert E | CEO, Pres | P - Purchase | $4.31 | +22,559 | 309,763 | +8% | +$97,229 | ||||||
2025-08-05 | VNRX | Volitionrx Ltd | Innes Guy Archibald | Dir | P - Purchase | $0.64 | +78,125 | 3,340,828 | +2% | +$50,000 | ||||||
2025-08-05 | VNRX | Volitionrx Ltd | Reynolds Cameron John | Pres, CEO | P - Purchase | $0.64 | +78,125 | 3,651,641 | +2% | +$50,000 | ||||||
2025-08-01 | XRX | Xerox Holdings Corp | Letier A. Scott | Dir | P - Purchase | $3.95 | +29,600 | 58,984 | +101% | +$116,920 | ||||||
2025-08-01 | QIND | Quality Industrial Corp. | Fusion Fuel Green Plc | 10% | P - Purchase | $0.02 | +2,000,000 | 80,312,334 | +3% | +$40,000 | ||||||
2025-08-01 | CLVT | Clarivate Plc | Cornick Kenneth L. | Dir | P - Purchase | $3.74 | +165,000 | 304,954 | +118% | +$617,100 | ||||||
2025-08-01 | PRME | Prime Medicine, Inc. | Gv 2021 Gp, L.L.C. | 10% | P - Purchase | $3.30 | +1,500,000 | 3,262,440 | +85% | +$4,950,000 | ||||||
M | 2025-08-01 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $1.05 | +2,000,000 | 67,612,859 | +3% | +$2,090,000 | |||||
2025-08-04 | XELB | Xcel Brands, Inc. | D Loren Robert W | CEO, COB, 10% | P - Purchase | $1.10 | +124,200 | 529,775 | +31% | +$136,620 | ||||||
2025-08-04 | XELB | Xcel Brands, Inc. | Disanto Mark | Dir | P - Purchase | $1.10 | +91,800 | 302,507 | +44% | +$100,980 | ||||||
D | 2025-08-01 | OBIO | Orchestra Biomed Holdings, Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $2.75 | +700,000 | 5,292,556 | +15% | +$1,925,000 | |||||
2025-07-31 | LRMR | Larimar Therapeutics, Inc. | Flynn James E | * Director by Deputization, 10% | P - Purchase | $3.20 | +9,375,000 | 30,606,974 | +44% | +$30,000,000 | ||||||
2025-08-04 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $2.75 | +20,000 | 903,931 | +2% | +$55,000 | ||||||
M | 2025-07-31 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $2.68 | +85,000 | 12,795,000 | +1% | +$227,921 | |||||
2025-07-31 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Dir | P - Purchase | $3.08 | +10,000 | 953,334 | +1% | +$30,800 | ||||||
2025-08-01 | PETS | Petmed Express Inc | Silvercape Investments Ltd | 10% | P - Purchase | $3.21 | +118,200 | 2,478,696 | +5% | +$379,422 | ||||||
2025-08-01 | PRME | Prime Medicine, Inc. | Nelsen Robert | Dir, 10% | P - Purchase | $3.30 | +3,030,300 | 18,502,974 | +20% | +$9,999,990 | ||||||
2025-08-01 | PRME | Prime Medicine, Inc. | Arch Venture Partners Xii, LLC | 10% | P - Purchase | $3.30 | +3,030,300 | 18,486,894 | +20% | +$9,999,990 | ||||||
2025-08-01 | PRME | Prime Medicine, Inc. | Arch Venture Partners X, LLC | 10% | P - Purchase | $3.30 | +3,030,300 | 18,486,894 | +20% | +$9,999,990 | ||||||
2025-07-29 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.08 | +371,470 | 7,107,606 | +6% | +$399,999 | ||||||
2025-07-30 | AURX | Nuo Therapeutics, Inc. | Sheedy Charles E | 10% | P - Purchase | $1.50 | +133,333 | 11,574,198 | +1% | +$200,000 | ||||||
2025-07-30 | NSPR | Inspiremd, Inc. | Roubin Gary S | Dir | P - Purchase | $2.42 | +41,322 | 608,425 | +7% | +$99,999 | ||||||
2025-07-30 | NSPR | Inspiremd, Inc. | Kester Thomas J | Dir | P - Purchase | $2.42 | +30,991 | 420,758 | +8% | +$74,998 | ||||||
2025-07-30 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $2.42 | +20,661 | 804,479 | +3% | +$50,000 | ||||||
2025-08-01 | TROX | Tronox Holdings Plc | Srivisal John | SVP, CFO | P - Purchase | $3.39 | +37,000 | 237,283 | +18% | +$125,478 | ||||||
2025-07-31 | AREC | American Resources Corp | Golden Properties Ltd. | 10% | P - Purchase | $1.12 | +1,000,000 | 13,389,960 | +8% | +$1,120,000 | ||||||
2025-08-01 | TROX | Tronox Holdings Plc | Engle Jeffrey A. | SVP, Commercial, Strategy | P - Purchase | $3.07 | +12,600 | 146,926 | +9% | +$38,682 | ||||||
2025-08-01 | TROX | Tronox Holdings Plc | Romano John D | CEO, Dir | P - Purchase | $3.09 | +100,000 | 1,333,485 | +8% | +$308,930 | ||||||
M | 2025-07-29 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $1.08 | +1,478,507 | 65,612,859 | +2% | +$1,591,573 | |||||
M | 2025-07-29 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $2.82 | +10,000 | 12,710,000 | 0% | +$28,161 | |||||
2025-07-30 | CRDF | Cardiff Oncology, Inc. | Pace Gary W | Dir | P - Purchase | $2.45 | +290,000 | 2,676,352 | +12% | +$710,500 | ||||||
M | 2025-06-11 | SNYR | Synergy Chc Corp. | Ross Jack | CEO, COB, 10% | P - Purchase | $2.85 | +27,900 | 4,795,757 | +1% | +$79,578 | |||||
2025-07-30 | TLRY | Tilray Brands, Inc. | Simon Irwin D | Pres, CEO | P - Purchase | $0.61 | +165,000 | 3,941,633 | +4% | +$100,106 | ||||||
M | 2025-07-28 | TLYS | Tilly'S, Inc. | Shay Capital LLC | 10% | P - Purchase | $1.95 | +100,000 | 3,300,000 | +3% | +$195,488 | |||||
DM | 2025-07-29 | LEXX | Lexaria Bioscience Corp. | Bunka Christopher | Dir | P - Purchase | $0.92 | +27,500 | 909,867 | +3% | +$25,241 | |||||
2025-07-11 | UPXI | Upexi, Inc. | Salkind Gene | Dir, 10% | P - Purchase | $4.94 | +20,243 | 585,370 | +4% | +$100,000 | ||||||
2025-07-28 | ABSI | Absci Corp | Busch Andreas | Chief Innovation Officer | P - Purchase | $3.04 | +50,000 | 327,264 | +18% | +$152,000 | ||||||
M | 2025-07-24 | LOOP | Loop Industries, Inc. | Hart Spencer | Dir | P - Purchase | $1.39 | +98,000 | 340,370 | +40% | +$136,381 | |||||
2025-07-23 | DMAC | Diamedica Therapeutics Inc. | Stahlberg Jan | 10% | P - Purchase | $3.50 | +1,542,857 | 6,764,465 | +30% | +$5,400,000 | ||||||
2025-07-23 | LOOP | Loop Industries, Inc. | Solomita Daniel | CEO, 10% | P - Purchase | $1.01 | +906,794 | 23,415,516 | +4% | +$915,499 | ||||||
2025-07-23 | LOOP | Loop Industries, Inc. | Sellyn Laurence G. | Dir | P - Purchase | $1.01 | +150,000 | 430,050 | +54% | +$151,440 | ||||||
2025-07-23 | LOOP | Loop Industries, Inc. | Catino Giovanni | Chief Revenue Officer | P - Purchase | $1.01 | +150,000 | 529,455 | +40% | +$151,440 | ||||||
2025-07-23 | LOOP | Loop Industries, Inc. | Stubina Jay Howard | Dir | P - Purchase | $1.01 | +150,000 | 487,915 | +44% | +$151,440 | ||||||
2025-07-23 | DMAC | Diamedica Therapeutics Inc. | Von Koch Thomas | 10% | P - Purchase | $3.50 | +2,857,142 | 8,383,577 | +52% | +$9,999,997 | ||||||
2025-07-23 | DMAC | Diamedica Therapeutics Inc. | Jacinto Richard II | 10% | P - Purchase | $3.50 | +400,000 | 4,958,823 | +9% | +$1,400,000 | ||||||
A | 2025-06-13 | BLNE | Beeline Holdings, Inc. | Liuzza Nicholas Reyland Jr | CEO, 10% | P - Purchase | $0.66 | +113,500 | 2,105,264 | +6% | +$74,914 | |||||
2025-07-11 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $4.94 | +161,943 | 2,246,261 | +8% | +$799,998 | ||||||
2025-07-22 | MERC | Mercer International Inc. | Kellogg Peter R | 10% | P - Purchase | $3.25 | +760,000 | 23,455,000 | +3% | +$2,470,000 | ||||||
2025-07-18 | BRCC | Brc Inc. | Welling Glenn W. | Dir, 10% | P - Purchase | $1.25 | +400,000 | 14,696,743 | +3% | +$500,000 | ||||||
2025-07-21 | PETS | Petmed Express Inc | Nina Capital Holdings Inc. | 10% | P - Purchase | $3.50 | +25,000 | 2,575,000 | +1% | +$87,425 | ||||||
2025-07-18 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $2.82 | +100,000 | 12,700,000 | +1% | +$282,000 | ||||||
2025-07-17 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.15 | +86,805 | 6,736,136 | +1% | +$99,999 | ||||||
2025-07-18 | PETS | Petmed Express Inc | Silvercape Investments Ltd | 10% | P - Purchase | $3.23 | +17,565 | 2,360,496 | +1% | +$56,735 | ||||||
2025-07-18 | BRCC | Brc Inc. | Hafer Evan | Dir, 10% | P - Purchase | $1.25 | +80,000 | 80,000 | New | +$100,000 | ||||||
2025-07-18 | BRCC | Brc Inc. | Kadenacy Stephen M | Dir | P - Purchase | $1.25 | +80,000 | 1,408,435 | +6% | +$100,000 | ||||||
2025-07-17 | PETS | Petmed Express Inc | Silvercape Investments Ltd | 10% | P - Purchase | $3.15 | +31,701 | 2,342,931 | +1% | +$99,858 | ||||||
2025-07-16 | RVYL | Ryvyl Inc. | S8 Global Fintech & Regtech Fund | 10% | P - Purchase | $0.36 | +200,000 | 3,604,845 | +6% | +$71,180 | ||||||
2025-07-15 | SSGC | Safespace Global Corp | Hillis Dustin Michael | Pres, Chief Strat Officer | P - Purchase | $0.42 | +122,500 | 7,254,500 | +2% | +$51,536 | ||||||
2025-07-14 | HIO | Western Asset High Income Opportunity Fund Inc. | Mason Peter Daniel Charles | Dir | P - Purchase | $4.02 | +10,000 | 10,000 | New | +$40,183 | ||||||
2025-07-14 | NTWK | Netsol Technologies Inc | Ghauri Naeem | Pres | P - Purchase | $3.85 | +18,279 | 459,853 | +4% | +$70,374 | ||||||
2025-07-11 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Dir | P - Purchase | $3.14 | +10,000 | 943,334 | +1% | +$31,400 | ||||||
2025-07-09 | BMNR | Bitmine Immersion Technologies, Inc. | Lee Thomas Jong | Dir | P - Purchase | $4.50 | +444,444 | 444,444 | New | +$1,999,998 | ||||||
D | 2025-07-11 | VBIX | Viewbix Inc. | Yoresh Eliyahu | Dir | P - Purchase | $4.86 | +5,144 | 10,635 | +94% | +$25,000 | |||||
M | 2025-07-08 | NXDT | Nexpoint Diversified Real Estate Trust | Laffer Arthur B | Dir | P - Purchase | $4.84 | +10,500 | 199,111 | +6% | +$50,820 | |||||
M | 2025-06-09 | MERC | Mercer International Inc. | Kellogg Peter R | 10% | P - Purchase | $3.70 | +142,020 | 22,695,000 | +1% | +$524,839 | |||||
M | 2025-07-02 | NXDT | Nexpoint Diversified Real Estate Trust | Laffer Arthur B | Dir | P - Purchase | $4.65 | +10,250 | 188,611 | +6% | +$47,658 | |||||
2025-07-01 | NRX | Neuraxis, Inc | Hannasch Brian | 10% | P - Purchase | $2.25 | +355,556 | 1,131,522 | +46% | +$800,001 | ||||||
2025-07-01 | CULP | Culp Inc | Culp Robert George IV | Pres, CEO | P - Purchase | $4.15 | +12,000 | 389,285 | +3% | +$49,800 | ||||||
M | 2025-07-01 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres, CEO, 10% | P - Purchase | $3.49 | +10,000 | 3,207,779 | 0% | +$34,879 | |||||
D | 2025-07-02 | CLRB | Cellectar Biosciences, Inc. | Caruso James V | CEO | P - Purchase | $4.99 | +10,000 | 11,638 | +611% | +$49,900 | |||||
D | 2025-07-02 | CLRB | Cellectar Biosciences, Inc. | Longcor Jarrod | COO | P - Purchase | $4.99 | +10,000 | 12,768 | +361% | +$49,900 | |||||
D | 2025-06-30 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $2.08 | +24,096 | 165,862 | +17% | +$49,999 | |||||
D | 2025-06-30 | BCDA | Biocardia, Inc. | Stertzer Simon H | Dir | P - Purchase | $2.08 | +72,289 | 315,875 | +30% | +$150,000 | |||||
D | 2025-06-30 | BCDA | Biocardia, Inc. | Blank Andrew Scott | Dir | P - Purchase | $2.08 | +72,289 | 348,058 | +26% | +$150,000 | |||||
2025-06-30 | PMNT | Perfect Moment Ltd. | Benaron Reeve | 10% | P - Purchase | $0.30 | +1,000,000 | 5,851,995 | +21% | +$300,000 | ||||||
2025-06-30 | PMNT | Perfect Moment Ltd. | Gottschalk Max | Dir, 10% | P - Purchase | $0.30 | +1,692,694 | 6,212,355 | +37% | +$507,808 | ||||||
2025-06-27 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $2.39 | +100,000 | 12,600,000 | +1% | +$239,000 | ||||||
2025-06-30 | PRME | Prime Medicine, Inc. | Liu David R. | 10% | P - Purchase | $2.52 | +21,000 | 20,240,945 | 0% | +$52,830 | ||||||
D | 2025-04-28 | PLUR | Pluri Inc. | Manieu Alexandre Weinstein | Dir, 10% | P - Purchase | $4.61 | +976,139 | 1,394,198 | +233% | +$4,500,001 | |||||
2025-06-30 | EONR | Eon Resources Inc. | Salvucci Joseph V Sr | Dir | P - Purchase | $0.34 | +123,951 | 1,629,121 | +8% | +$41,957 | ||||||
2025-06-30 | NG | Novagold Resources Inc | Kyle Hume D. | Dir | P - Purchase | $4.10 | +10,000 | 22,348 | +81% | +$41,000 | ||||||
D | 2025-06-27 | CURV | Torrid Holdings Inc. | Fund 1 Investments, LLC | 10% | P - Purchase | $3.20 | +8,500 | 10,433,112 | 0% | +$27,229 | |||||
M | 2025-06-27 | RVYL | Ryvyl Inc. | S8 Global Fintech & Regtech Fund | 10% | P - Purchase | $0.80 | +114,491 | 3,504,845 | +3% | +$91,050 | |||||
2025-06-27 | TERN | Terns Pharmaceuticals, Inc. | Gengos Andrew | CFO | P - Purchase | $3.93 | +10,000 | 25,000 | +67% | +$39,283 | ||||||
M | 2025-06-26 | TLYS | Tilly'S, Inc. | Shay Capital LLC | 10% | P - Purchase | $1.37 | +232,578 | 6,340,065 | +4% | +$318,270 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |